| Literature DB >> 27119584 |
Jiao Jiao Li1, Yue Li Tian1, Hong Lin Zhai1, Min Lv1, Xiao Yun Zhang1.
Abstract
DYRK1A is characterized by the early development and regulation of neuronal proliferation, and its over expression gives rise to neurological abnormalities. As the promising DYRK1A inhibitors, the binding mechanism between DYRK1A and pyrido[2,3-d]pyrimidines derivatives at molecular level are still veiled. In this article, it was achieved to get the structural insights into pyrido[2,3-d]pyrimidines derivatives as DYRK1A inhibitors by means of comprehensive computational approaches involving molecular docking, molecular dynamics simulation, free energy calculation, and energy decomposition analysis. The calculated energy values were highly consistent with the experimental activities. Based on the individual energy terms analysis, the van der Waals interaction was the major leading force in the DYRK1A-ligand interaction. Lys188 was the important residue that formed the hydrogen bond, which improved the inhibitory activity. Furthermore, four novel inhibitors with higher predicted activity were designed based on the obtained findings and confirmed by molecular simulations. Our study is expected to provide significant drug design strategy for the development of more promising DYRK1A inhibitors. Proteins 2016; 84:1108-1123.Entities:
Keywords: DYRK1A; binding mechanism; molecular design; molecular docking; molecular dynamics
Mesh:
Substances:
Year: 2016 PMID: 27119584 DOI: 10.1002/prot.25056
Source DB: PubMed Journal: Proteins ISSN: 0887-3585